跳至主要内容
临床试验/2024-519024-25-00
2024-519024-25-00招募中2 期

Faecal Bacteriotherapy for Postantibiotic Diarrhoea in Critically Ill Patients – Randomised Controlled Trial

Fakultni Nemocnice Kralovske Vinohrady1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2024年12月3日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
36
试验地点
1
主要终点
Percentage of patients with treatment failure at day 7 after randomisation.

研究概览

简要总结

Percentage of patients with treatment failure at day 7 after randomisation. Treatment failure is defined as either failure to administer allocated treatment for any reason or the presence of diarrhoea on day 7 after randomisation.

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • Signed informed consent
  • Age > 18 yrs.
  • In-patient in ICU or HDU (incl. burn unit) and expected to stay for >7 days
  • Diarrhoea following antibiotic treatment defined as 3 or more stools per day or Bristol type 7 stool in the volume >300 ml/day if stool derivative device is in place, persisting for 24 hours despite enteral feeding formula has been stopped

排除标准

  • Death appears imminent or ceilings of care put in place, presence of new-onset sepsis defined as per 2016 definition, lactate >2.0 mM, colon diameter > 9 cm on plain AXR, the necessity of ongoing antibiotic treatment for another reasons.
  • Unable to tolerate enema for any reason (e.g. surgery of the GI tract in the past year).
  • Pregnant and lactating woman
  • Patients with a history of severe anaphylactic food allergy, any other reason which – as per judgement of the treating clinician – makes faecal transplantation unsafe or not feasible

结局指标

主要结局

Percentage of patients with treatment failure at day 7 after randomisation.

Percentage of patients with treatment failure at day 7 after randomisation.

次要结局

  • Composite number of adverse events such as new-onset sepsis, toxic mega-colon, positive post FBT blood culture, or other SAE assessed by the physi-cian-in-charge as possibly related to FBT.
  • SOFA score at days 4 and 7.
  • Percentage of patients that are recurrence-free at time of hospital discharge or day 28, whichever occur earlier.
  • Subgroup analysis will be performed for patients who are C. dif. positive vs. negative and those who will receive antibiotics for a new extraabdominal in-fection vs. those who do not.

研究者

发起方
Fakultni Nemocnice Kralovske Vinohrady
申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Dr Frantisek Duska, PhD

Scientific

Fakultni Nemocnice Kralovske Vinohrady

研究点 (1)

Loading locations...

相似试验